Robert Howard, Director, Strategy and Portfolio Analysis, Janssen Global Services
Peter Ray, Bristol-Myers Squibb Company, United States
Elizabeth Ng, Biomarin Pharmaceuticals, United States
Organizations need to tailor their portfolio management approach to their specific needs and their relative level of organization maturity, considering the size of the portfolio being managed, the phases of development, and the degree of resource constraint being faced, all with the right balance of speed and rigor. The panel discussion will involve a cross-section of practitioners from industry, sharing experiences of what has and has not worked at their organizations.
Identify the most common barriers to successful implementation of portfolio management in the biopharma environment
Examine opportunities for improvement in portfolio management
Describe how to tailor a process to the capabilities of the organization and evolve it over time.
Audio Synchronized to PowerPoint